This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Hiroshima University, Takeda Pharmaceutical Company Limited. Active years: 2012.
Company Filing History:
1 out of 258 
1 out of 1,226 
Years Active: 2012
Title: Osamu Hazeki: Innovator in Drug Screening Methods
Introduction
Osamu Hazeki is a notable inventor based in Hiroshima, Japan. He has made significant contributions to the field of drug discovery, particularly in the development of methods for screening substances that target specific cellular mechanisms.
Latest Patents
One of his key patents is a screening method for a substance that binds to an intracellular region of TLR4. This invention provides a method for screening drugs aimed at the prophylaxis or treatment of various diseases, including cardiac disease, autoimmune disease, inflammatory disease, central nervous system disease, infectious disease, sepsis, severe sepsis, and septic shock. The method involves selecting a substance that binds to TLR4 and inhibits signal transduction from the molecule. Additionally, it includes a kit that contains a cell expressing wild-type TLR4 and a cell expressing a mutant TLR4, which can detect signals from TLR4 using a reporter gene as an index.
Career Highlights
Osamu Hazeki has worked with prominent institutions, including Hiroshima University and Takeda Pharmaceutical Company Limited. His work has been instrumental in advancing the understanding of TLR4's role in various diseases and developing potential therapeutic strategies.
Collaborations
He has collaborated with notable colleagues, including Kaoru Hazeki and Masayuki Ii, contributing to the collective knowledge in the field of drug discovery.
Conclusion
Osamu Hazeki's innovative work in drug screening methods highlights his significant impact on medical research and potential therapeutic advancements. His contributions continue to influence the development of treatments for critical diseases.